Abstract:Programmed death-ligand 1 (PD-L1) plays an important role in T cell tolerance and tumor immune escape, which has been reported to be a prognostic factor in various malignancies. However, only a few studies about PD-L1 in nasopharyngeal carcinoma (NPC) are available, and the reported prognostic role of PD-L1 in NPC patients remains controversial. In this study, we aimed to investigate the alterations of PD-L1 expression on tumor cells in NPC patients with and without metastasis. Furthermore, we would explore the correlation of PD-L1 expression on tumor cells and serum Epstein-Barr virus (EBV) DNA load. Pathologically confirmed NPC treated with intensity-modulated radiation therapy were recruited for the study. Formalin-fixed, paraffin-embedded tissues were studied by immunohistochemistry staining. The expression of PD-L1 on tumor cells was detected and the staining results were evaluated by positive tumor cell percentage. Clinical characteristics and qRT-PCR data of serum EBV DNA load before treatment were collected. The optimal cut-off value for PD-L1 staining was determined by the area under the curve of the receiver operating characteristic (ROC). The Chi-square test was used to evaluate results with SPSS 25.0. A total of 78 patients were included in this study, with median follow up 52.8 months (range 12-108 months). The median age was 44 years old (range 22 –65 years). Among those 78 patients, 43(55%) patients had metastasis, 35 (45%) did not have metastasis. PD-L1 expression on tumor cells was detected in 66 patients (66/78, 85%). When staining with PD-L1 on >45% tumor cells, PD-L1 expression was classified as being at a high level according to the ROC curve analysis. In metastasis group, 25 out of 43 patients showed high PD-L1 expression, while in non-metastasis group only 7 out of 35 patients showed high PD-L1 expression (p=0.001). We observed that more patients in metastasis group had detectable serum EBV DNA load than non-metastasis group (p=0.007). In order to study the effect of EBV on PD-L1 expression, we explored the correlation of PD-L1 expression on tumor cells and serum EBV DNA status (before treatment). Our data showed that PD-L1 expression was not significantly correlated with EBV DNA load among all the patients (p= 0.554). Our results revealed that PD-L1 might be a potential metastatic biomarker for NPC patients. Furthermore, EBV status was not significantly correlated with PD-L1 expression. PD-1/PD-L1 pathway might be a promising therapy target for advanced NPC.

Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis

Staining of Interleukin-10 Predicts Clinical Outcome in Patients with Nasopharyngeal Carcinoma.

Peripheral NK-cell immunophenotypes predict progression in nasopharyngeal carcinoma patients.

Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes.

CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer

Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma.

High PD-L1 Expression Predicts Metastasis in Nasopharyngeal Carcinoma

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load

Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma

Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Integrated analysis of bulk and single-cell RNA sequencing reveals the interaction of PKP1 and tumor-infiltrating B cells and their therapeutic potential for nasopharyngeal carcinoma

Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment

Prognostic Significance of Tumor Infiltrating Lymphocytes (tils) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

PD-1 High Expression Predicts Lower Local Disease Control in Stage IV M0 Nasopharyngeal Carcinoma

Prognostic Significance of Tumor-Infiltrating Lymphocytes in Nondisseminated Nasopharyngeal Carcinoma: A Large-Scale Cohort Study.

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes

Decreased Expression of the NKG2D Ligand ULBP4 May Be an Indicator of Poor Prognosis in Patients with Nasopharyngeal Carcinoma